Ajanta Pharma Limited

BSE:532331 Stock Report

Market Cap: ₹367.9b

Ajanta Pharma Future Growth

Future criteria checks 3/6

Ajanta Pharma is forecast to grow earnings and revenue by 16.4% and 11.4% per annum respectively. EPS is expected to grow by 16.4% per annum. Return on equity is forecast to be 23.8% in 3 years.

Key information

16.4%

Earnings growth rate

16.4%

EPS growth rate

Pharmaceuticals earnings growth17.7%
Revenue growth rate11.4%
Future return on equity23.8%
Analyst coverage

Good

Last updated11 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BSE:532331 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202759,42913,17910,90311,8097
3/31/202653,12311,2048,4449,79910
3/31/202547,2349,5647,8229,2199
9/30/202444,9088,7509,12711,625N/A
6/30/202443,3268,538N/AN/AN/A
3/31/202442,0878,1626,3277,851N/A
12/31/202340,3657,357N/AN/AN/A
9/30/202339,0316,6026,6108,199N/A
6/30/202338,1286,215N/AN/AN/A
3/31/202337,4265,8806,1767,921N/A
12/31/202237,3116,169N/AN/AN/A
9/30/202235,9726,7425,0276,613N/A
6/30/202235,4397,136N/AN/AN/A
3/31/202233,4107,1274,1295,617N/A
12/31/202132,2757,207N/AN/AN/A
9/30/202131,3847,0563,6075,379N/A
6/30/202129,6956,799N/AN/AN/A
3/31/202128,8976,5394,0475,763N/A
12/31/202028,1486,238N/AN/AN/A
9/30/202027,1735,5473,5935,334N/A
6/30/202026,4415,008N/AN/AN/A
3/31/202025,8794,6772,1744,568N/A
12/31/201924,2114,274N/AN/AN/A
9/30/201922,5503,8681,4514,409N/A
6/30/201921,5633,958N/AN/AN/A
3/31/201920,5543,8703153,745N/A
12/31/201820,6543,926N/AN/AN/A
9/30/201821,6744,731N/AN/AN/A
6/30/201821,6364,796N/AN/AN/A
3/31/201821,2584,686N/A2,811N/A
12/31/201720,5904,882N/AN/AN/A
9/30/201720,0504,833N/AN/AN/A
6/30/201719,8054,821N/AN/AN/A
3/31/201719,8335,068N/A6,093N/A
12/31/201619,3864,908N/AN/AN/A
9/30/201618,8214,622N/AN/AN/A
6/30/201618,0724,350N/AN/AN/A
3/31/201617,3404,156N/A3,261N/A
12/31/201516,8093,692N/AN/AN/A
9/30/201516,1603,510N/AN/AN/A
6/30/201515,5023,340N/AN/AN/A
3/31/201514,7363,099N/A2,794N/A
3/31/201412,0832,339N/A2,124N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 532331's forecast earnings growth (16.4% per year) is above the savings rate (6.7%).

Earnings vs Market: 532331's earnings (16.4% per year) are forecast to grow slower than the Indian market (18% per year).

High Growth Earnings: 532331's earnings are forecast to grow, but not significantly.

Revenue vs Market: 532331's revenue (11.4% per year) is forecast to grow faster than the Indian market (10.5% per year).

High Growth Revenue: 532331's revenue (11.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 532331's Return on Equity is forecast to be high in 3 years time (23.8%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y